Emerging Infectious Diseases (Feb 2021)

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

  • Maryam Shakiba,
  • Maryam Nazemipour,
  • Arsalan Salari,
  • Fardin Mehrabian,
  • Seyed Saeed H. Nazari,
  • Seyed Mahmoud Rezvani,
  • Zahra Ghasempour,
  • Abtin Heidarzadeh,
  • Mohammad Ali Mansournia

DOI
https://doi.org/10.3201/eid2702.201960
Journal volume & issue
Vol. 27, no. 2
pp. 636 – 638

Abstract

Read online

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%).

Keywords